Journal article icon

Journal article

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial

Publication status:
In press
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1016/s0140-6736(19)31817-3

Authors


Publisher:
Elsevier
Journal:
Lancet More from this journal
Publication date:
2019-09-05
Acceptance date:
2019-07-08
DOI:
EISSN:
1474-547X
ISSN:
0140-6736


Language:
English
Keywords:
Pubs id:
pubs:1054887
UUID:
uuid:dc9fd6d7-053b-4aad-8fa5-8085fa0b5a8d
Local pid:
pubs:1054887
Source identifiers:
1054887
Deposit date:
2019-09-23
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP